Letter to the Editor

Abstract

We appreciate the comments concerning our manuscript, Rising hypospadias rates: disproving a myth (J Pediatr Urol 2010;6:37–39). We agree that uniformity, among population study groups, would provide more consistent data. However, the data set analyzed for our study is more than 20 years in length and represents one of the longest databases available. This data accrued over a long study period would appear to be more robust than data collected over a 2-year period by Peirik et al. (A high hypospadias rate in the Netherlands. Hum Reprod 2002;17:1112–1115). Re: Harry Fisch et al.: Rising hypospadia rates: Disproving a myth. (Journal of Pediatric Urology 2010; 6: 37–39)Journal of Pediatric UrologyVol. 6Issue 5PreviewWe read with interest the report by Fisch, Hyun and Hensle in the January issue of the Journal of Pediatric Urology[1]. The authors have reviewed the data from the birth registries of New York State, California, Washington, Scotland, and the European registries, and have concluded that the prevalence of hypospadias did not rise significantly during 1982–83 to 2002–05. In addition, based on this data, they have refuted the hypothesis suggesting an increase in the incidence of hypospadias due to the potential effects of ‘endocrine disruptors’ such as phthalates and bisphenol-A on male reproductive health. Full-Text PDF